Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
KUNLUN ENERGY
00135
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 36.69%-6.4M | -45.65%-25.54M | 94.04%-399.09K | -5.02%-6.83M | -5,185.86%-8.2M | -141.89%-10.11M | -29.17%-17.53M | 65.42%-6.69M | -842.74%-6.51M | -108.20%-155.12K |
| Net income from continuing operations | -184.85%-4.65M | -128.84%-28.36M | -173.78%-16.58M | 104.72%302.79K | -119.10%-10.44M | -133.72%-1.63M | 43.38%-12.39M | 37.45%-6.06M | -3,280.32%-6.41M | -44.02%-4.77M |
| Operating gains losses | -21.78%-3.75M | 183.19%5.42M | 285.97%5M | -240.76%-3M | 7,989.82%6.5M | 47.56%-3.08M | -231.57%-6.52M | -168.92%-2.69M | 114.20%2.13M | -101.54%-82.37K |
| Depreciation and amortization | -33.64%1.45M | -55.49%6.98M | -57.65%1.61M | -59.18%1.6M | -60.16%1.59M | -45.11%2.19M | 4.28%15.69M | -25.13%3.81M | 10.61%3.92M | 25.83%3.98M |
| Asset impairment expenditure | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Unrealized gains and losses of investment securities | 742.13%3.76M | 2,443.48%3.64M | 4,937.64%3.85M | 139.05%71.35K | -510.11%-732.95K | 296.27%446.98K | -162.39%-155.24K | -40.21%76.48K | -237.55%-182.71K | 207.50%178.72K |
| Remuneration paid in stock | 63.25%1.35M | 215.31%8.03M | 237.56%4.32M | 16.48%601.47K | 352.07%2.28M | 236.54%828.76K | 57.15%2.55M | 216.98%1.28M | 54.74%516.37K | 4.67%504.14K |
| Deferred tax | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Other non cashItems | 45.17%-2.51M | 3.15%-19.24M | 7.22%-4.65M | -26.61%-5.05M | -31.80%-4.96M | 35.53%-4.58M | -19.69%-19.86M | 74.48%-5.01M | -139.10%-3.99M | 18.89%-3.76M |
| Change In working capital | 52.02%-2.05M | -163.82%-2.02M | 218.61%6.05M | 45.18%-1.36M | -163.29%-2.43M | -4,222.32%-4.28M | 88.22%3.16M | 308.64%1.9M | -271.48%-2.48M | 281.06%3.84M |
| -Change in receivables | 98.56%-16.29K | -326.30%-1.86M | 35.39%2.21M | -16,345.71%-1.25M | -112.84%-1.69M | -24,916.48%-1.13M | 166.19%823.49K | 265.77%1.63M | -101.06%-7.59K | -99.18%-794.57K |
| -Change in payables and accrued expense | 35.29%-2.04M | -106.52%-152.18K | 1,327.06%3.85M | 95.46%-112.45K | -115.96%-739.62K | -3,231.61%-3.15M | -20.09%2.33M | 269.70%269.47K | -439.50%-2.48M | 229.49%4.64M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 36.69%-6.4M | -45.65%-25.54M | 94.04%-399.09K | -5.02%-6.83M | -5,185.86%-8.2M | -141.89%-10.11M | -29.17%-17.53M | 65.42%-6.69M | -842.74%-6.51M | -108.20%-155.12K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -523.80%-16.17M | -182.92%-12.2M | -312.07%-14.01M | -512.31%-7.61M | 859.59%5.6M | -32.83%3.82M | 22.56%14.72M | -65.32%6.61M | 1,873.08%1.84M | 128.16%583.43K |
| Net PPE purchase and sale | -1,839.96%-15.17M | -348.92%-17.02M | -2,271.87%-14.01M | ---1.45M | 75.77%-775.26K | ---782.11K | -51.16%-3.79M | -847.55%-590.78K | --0 | -54.47%-3.2M |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 |
| Net investment purchase and sale | -121.75%-1M | -73.99%4.81M | ---- | ---- | 68.47%6.37M | -19.06%4.6M | -3.93%18.51M | ---- | ---- | --3.78M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -523.80%-16.17M | -182.92%-12.2M | -312.07%-14.01M | -512.31%-7.61M | 859.59%5.6M | -32.83%3.82M | 22.56%14.72M | -65.32%6.61M | 1,873.08%1.84M | 128.16%583.43K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -64.65%1.91M | 2,640.78%114.51M | 7,108.87%86.68M | 339.74%16.37M | 2,928.62%6.08M | 1,114.02%5.39M | 7,346.17%4.18M | 654.60%1.2M | 1,977.18%3.72M | 38.48%-214.93K |
| Net issuance payments of debt | --0 | 86.34%-113.13K | --0 | 98.20%-5K | 93.02%-15K | 82.66%-93.13K | 18.59%-828.04K | 133.39%201.66K | 36.65%-277.82K | 50.00%-214.93K |
| Net common stock issuance | --0 | 2,512.98%104.68M | 12,086,521.43%84.61M | 200.54%12.02M | --1.57M | 118,692.54%6.48M | 273.28%4.01M | -99.82%700 | 1,564.97%4M | --0 |
| Proceeds from stock option exercised by employees | ---- | --10.95M | --2.07M | --4.35M | ---- | ---- | --0 | --0 | --0 | ---- |
| Net other financing activities | 290.50%1.91M | -200.00%-1M | --0 | --0 | --0 | ---1M | --1M | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -64.65%1.91M | 2,640.78%114.51M | 7,108.87%86.68M | 339.74%16.37M | 2,928.62%6.08M | 1,114.02%5.39M | 7,346.17%4.18M | 654.60%1.2M | 1,977.18%3.72M | 38.48%-214.93K |
| Net cash flow | ||||||||||
| Beginning cash position | 4,505.84%78.48M | 399.28%1.7M | 955.72%6.21M | 180.48%4.28M | -38.77%804.37K | 399.28%1.7M | -81.56%341.27K | -32.00%588.61K | 422.79%1.53M | 59.84%1.31M |
| Current changes in cash | -2,197.32%-20.66M | 5,534.34%76.77M | 6,379.48%72.26M | 305.76%1.93M | 1,530.22%3.48M | -192.51%-899.52K | 190.28%1.36M | 312.70%1.12M | -263.63%-938.45K | 140.28%213.39K |
| End cash Position | 7,087.45%57.81M | 4,505.84%78.48M | 4,505.84%78.48M | 955.72%6.21M | 180.48%4.28M | -38.77%804.37K | 399.28%1.7M | 399.28%1.7M | -32.00%588.61K | 422.79%1.53M |
| Free cash from | -98.12%-21.57M | -100.87%-42.83M | -17.14%-8.53M | -121.93%-14.44M | -167.49%-8.97M | -160.62%-10.89M | -28.60%-21.32M | 62.49%-7.29M | -942.85%-6.51M | -1,760.07%-3.36M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.